| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |